NetScientific PLC (LON:NSCI) said its portfolio company, PDS Biotechnology Corporation (NASDAQ:PDSB), has closed its underwritten public offering of shares.
The shares were offered at US$8.50 a pop. NetScientific participated in the share offering, buying 60,000 shares, which means its stake in PDS is about 4.72%.
The gross proceeds to PDS Biotech from this offering, before deducting underwriting discounts, commissions and other offering expenses were about US$51.7mln.
READ NetScientific follows its money as investee company announces plans to raise US$45mln
